Founded Date: 2020-01-01
Funding Status: Early Stage Venture
Total Funding: 37200000.0
Headquarters: United States
Last Funding Date: 2022-06-08
Investors Number: 7.0
Last Funding Type: Series A
Industry: Early Drug Development